Staphylococcus aureus: A Continuously Evolving and Formidable Pathogen in the Neonatal Intensive Care Unit

Clinics in Perinatology

Volumn 37, Issue 3, 2010, Pages 535-546

  Carey, Alison J ^a   Long, Sarah S ^a  

^a ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

MRSA; MSSA; Neonates; Staphylococcus aureus

Indexed keywords

GENTAMICIN; PSEUDOMONIC ACID; RIFAMPICIN; VANCOMYCIN; VIRULENCE FACTOR;

ADJUVANT THERAPY; ANTIBIOTIC RESISTANCE; BACTERIAL ENDOCARDITIS; BACTERIAL VIRULENCE; CELLULITIS; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; LOW DRUG DOSE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NEPHROTOXICITY; NEWBORN; NEWBORN CARE; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; NONHUMAN; OSTEOMYELITIS; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STRAIN DIFFERENCE; SURGICAL INFECTION; VERY LOW BIRTH WEIGHT;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DISEASE OUTBREAKS; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; UNITED STATES;

EID: 77956146862     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2010.05.002     Document Type: Review

References (74)

1. Sanford H.N. Care of the skin of the newborn infant. J Pediatr 1937, 11:68.
2. Feldman F., Annunziata D. Staphylococcus aureus infections in the newborn infant. J Pediatr 1952, 41(4):399-402.
3. Colbeck J.C. An extensive outbreak of staphylococcal infections in maternity units; the use of bacteriophage typing in investigation and control. Can Med Assoc J 1949, 61(6):557-568.
4. Shinefield H.R., Ribble J.C., Boris M., et al. Bacterial interference: its effect on nursery-acquired infection with Staphylococcus aureus. I. Preliminary observations on artificial colonization of newborns. Am J Dis Child 1963, 105:646-654.
5. Shinefield H.R., Sutherland J.M., Ribble J.C., et al. Bacterial interference: its effect on nursery-acquired infection with Staphylococcus aureus. II. The Ohio epidemic. Am J Dis Child 1963, 105:655-662.
6. Shinefield H.R., Boris M., Ribble J.C., et al. Bacterial interference: its effect on nursery-acquired infection with Staphylococcus aureus. III. The Georgia epidemic. Am J Dis Child 1963, 105:663-673.
7. Shinefield H.R., Ribble J.C., Eichenwald H.F., et al. Bacterial interference: its effect on nursery-acquired infection with Staphylococcus aureus. V. An analysis and interpretation. Am J Dis Child 1963, 105:683-688.
8. Boyce J.M. Increasing prevalence of methicillin-resistant Staphylococcus aureus in the United States. Infect Control Hosp Epidemiol 1990, 11(12):639-642.
9. Weeks J.L., Garcia-Prats J.A., Baker C.J. Methicillin-resistant Staphylococcus aureus osteomyelitis in a neonate. JAMA 1981, 245(16):1662-1664.
10. Gerber J.S., Coffin S.E., Smathers S.A., et al. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States. Clin Infect Dis 2009, 49(1):65-71.
11. Moran G.J., Krishnadasan A., Gorwitz R.J., et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006, 355(7):666-674.
12. Alfaro C., Mascher-Denen M., Fergie J., et al. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in patients admitted to Driscoll Children's Hospital. Pediatr Infect Dis J 2006, 25(5):459-461.
13. Lowy F.D., Aiello A.E., Bhat M., et al. Staphylococcus aureus colonization and infection in New York State prisons. J Infect Dis 2007, 196(6):911-918.
14. Lee N.E., Taylor M.M., Bancroft E., et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis 2005, 40(10):1529-1534.
15. Zinderman C.E., Conner B., Malakooti M.A., et al. Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg Infect Dis 2004, 10(5):941-944.
16. Saiman L., O'Keefe M., Graham P.L., et al. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 2003, 37(10):1313-1319.
17. James L., Gorwitz R.J., Jones R.C., et al. Methicillin-resistant Staphylococcus aureus infections among healthy full-term newborns. Arch Dis Child Fetal Neonatal Ed 2008, 93(1):F40-F44.
18. Chen K.T., Huard R.C., Della-Latta P., et al. Prevalence of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in pregnant women. Obstet Gynecol 2006, 108(3 Pt 1):482-487.
19. Reusch M., Ghosh P., Ham C., et al. Prevalence of MRSA colonization in peripartum mothers and their newborn infants. Scand J Infect Dis 2008, 40(8):667-671.
20. Creech C.B., Litzner B., Talbot T.R., et al. Frequency of detection of methicillin-resistant Staphylococcus aureus from rectovaginal swabs in pregnant women. Am J Infect Control 2010, 38(1):72-74.
21. Stoll B.J., Hansen N., Fanaroff A.A., et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002, 347(4):240-247.
22. Stoll B.J., Hansen N.I., Higgins R.D., et al. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatr Infect Dis J 2005, 24(7):635-639.
23. Stoll B.J., Hansen N., Fanaroff A.A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002, 110(2 Pt 1):285-291.
24. Lessa F.C., Edwards J.R., Fridkin S.K., et al. Trends in incidence of late-onset methicillin-resistant Staphylococcus aureus infection in neonatal intensive care units: data from the National Nosocomial Infections Surveillance System, 1995-2004. Pediatr Infect Dis J 2009, 28(7):577-581.
25. Carey A.J., Duchon J., Della-Latta P., et al. The epidemiology of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit, 2000-2007. J Perinatol 2010, 30(2):135-139.
26. Healy C.M., Hulten K.G., Palazzi D.L., et al. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis 2004, 39(10):1460-1466.
27. McAdams R.M., Ellis M.W., Trevino S., et al. Spread of methicillin-resistant Staphylococcus aureus USA300 in a neonatal intensive care unit. Pediatr Int 2008, 50(6):810-815.
28. Fortunov R.M., Hulten K.G., Hammerman W.A., et al. Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics 2006, 118(3):874-881.
29. Chavez-Bueno S., Bozdogan B., Katz K., et al. Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas. Antimicrob Agents Chemother 2005, 49(6):2283-2288.
30. Buckingham S.C., McDougal L.K., Cathey L.D., et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital. Pediatr Infect Dis J 2004, 23(7):619-624.
31. Tenover F.C., McDougal L.K., Goering R.V., et al. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol 2006, 44(1):108-118.
32. Diederen B.M., Kluytmans J.A. The emergence of infections with community-associated methicillin resistant Staphylococcus aureus. J Infect 2006, 52(3):157-168.
33. Carey A.J., Saiman L., Polin R.A. Hospital-acquired infections in the NICU: epidemiology for the new millennium. Clin Perinatol 2008, 35(1):223-249. x.
34. Carey A.J., Della-Latta P., Huard R., et al. Changes in the molecular epidemiological characteristics of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2010, 31(6):613-619.
35. McCaskill M.L., Mason E.O., Kaplan S.L., et al. Increase of the USA300 clone among community-acquired methicillin-susceptible Staphylococcus aureus causing invasive infections. Pediatr Infect Dis J 2007, 26(12):1122-1127.
36. Graham P.L., Lin S.X., Larson E.L. A U.S. population-based survey of Staphylococcus aureus colonization. Ann Intern Med 2006, 144(5):318-325.
37. Davis S.L., Rybak M.J., Amjad M., et al. Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2006, 27(10):1025-1031.
38. Tsuji B.T., Rybak M.J., Cheung C.M., et al. Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents. Diagn Microbiol Infect Dis 2007, 58(1):41-47.
39. Villaruz A.E., Bubeck Wardenburg J., Khan B.A., et al. A point mutation in the agr locus rather than expression of the Panton-Valentine leukocidin caused previously reported phenotypes in Staphylococcus aureus pneumonia and gene regulation. J Infect Dis 2009, 200(5):724-734.
40. Varshney A.K., Martinez L.R., Hamilton S.M., et al. Augmented production of Panton-Valentine leukocidin toxin in methicillin-resistant and methicillin-susceptible Staphylococcus aureus is associated with worse outcome in a murine skin infection model. J Infect Dis 2010, 201(1):92-96.
41. Diep B.A., Gill S.R., Chang R.F., et al. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet 2006, 367(9512):731-739.
42. Mongkolrattanothai K., Aldag J.C., Mankin P., et al. Epidemiology of community-onset Staphylococcus aureus infections in pediatric patients: an experience at a Children's Hospital in central Illinois. BMC Infect Dis 2009, 9:112.
43. Kaplan S.L., Hulten K.G., Gonzalez B.E., et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005, 40(12):1785-1791.
44. Faden H., Rose R., Lesse A., et al. Clinical and molecular characteristics of staphylococcal skin abscesses in children. J Pediatr 2007, 151(6):700-703.
45. Miller L.G., Perdreau-Remington F., Bayer A.S., et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation. Clin Infect Dis 2007, 44(4):471-482.
46. Davenport M., Doig C.M. Wound infection in pediatric surgery: a study in 1,094 neonates. J Pediatr Surg 1993, 28(1):26-30.
47. Korakaki E., Aligizakis A., Manoura A., et al. Methicillin-resistant Staphylococcus aureus osteomyelitis and septic arthritis in neonates: diagnosis and management. Jpn J Infect Dis 2007, 60(2-3):129-131.
48. Friedland I.R., du Plessis J., Cilliers A. Cardiac complications in children with Staphylococcus aureus bacteremia. J Pediatr 1995, 127(5):746-748.
49. Jahamy H., Ganga R., Al Raiy B., et al. Staphylococcus aureus skin/soft-tissue infections: the impact of SCCmec type and Panton-Valentine leukocidin. Scand J Infect Dis 2008, 40(8):601-606.
50. Sdougkos G., Chini V., Papanastasiou D.A., et al. Community-associated Staphylococcus aureus infections and nasal carriage among children: molecular microbial data and clinical characteristics. Clin Microbiol Infect 2008, 14(11):995-1001.
51. Fowler V.G., Justice A., Moore C., et al. Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis 2005, 40(5):695-703.
52. Centers for Disease Control and Prevention (CDC) Community-associated methicillin-resistant Staphylococcus aureus infection among healthy newborns-Chicago and Los Angeles County, 2004. MMWR Morb Mortal Wkly Rep 2006, 55(12):329-332.
53. Nguyen D.M., Bancroft E., Mascola L., et al. Risk factors for neonatal methicillin-resistant Staphylococcus aureus infection in a well-infant nursery. Infect Control Hosp Epidemiol 2007, 28(4):406-411.
54. Bratu S., Eramo A., Kopec R., et al. Community-associated methicillin-resistant Staphylococcus aureus in hospital nursery and maternity units. Emerg Infect Dis 2005, 11(6):808-813.
55. Steinkraus G., White R., Friedrich L. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. J Antimicrob Chemother 2007, 60(4):788-794.
56. Howden B.P., Johnson P.D., Charles P.G., et al. Failure of vancomycin for treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2004, 39(10):1544. [author reply: 1544-5].
57. Soriano A., Marco F., Martinez J.A., et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2008, 46(2):193-200.
58. Frymoyer A., Hersh A.L., Benet L.Z., et al. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J 2009, 28(5):398-402.
59. Cosgrove S.E., Vigliani G.A., Fowler V.G., et al. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis 2009, 48(6):713-721.
60. Deresinski S. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2009, 49(7):1072-1079.
61. Kaplan S.L. Community-acquired methicillin-resistant Staphylococcus aureus infections in children. Semin Pediatr Infect Dis 2006, 17(3):113-119.
62. Gonzalez C., Rubio M., Romero-Vivas J., et al. Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 1999, 29(5):1171-1177.
63. Lamp K.C., Rybak M.J., Bailey E.M., et al. In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin. Antimicrob Agents Chemother 1992, 36(12):2709-2714.
64. Rose W.E., Poppens P.T. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus. J Antimicrob Chemother 2009, 63(3):485-488.
65. Seybold U., Halvosa J.S., White N., et al. Emergence of and risk factors for methicillin-resistant Staphylococcus aureus of community origin in intensive care nurseries. Pediatrics 2008, 122(5):1039-1046.
66. Gerber S.I., Jones R.C., Scott M.V., et al. Management of outbreaks of methicillin-resistant Staphylococcus aureus infection in the neonatal intensive care unit: a consensus statement. Infect Control Hosp Epidemiol 2006, 27(2):139-145.
67. Weems J.J., Steinberg J.P., Filler S., et al. Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2006, 50(8):2751-2755.
68. DeJonge M., Burchfield D., Bloom B., et al. Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants. J Pediatr 2007, 151(3):260-265. 265.e1.
69. Miller M.A., Dascal A., Portnoy J., et al. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996, 17(12):811-813.
70. Simor A.E., Stuart T.L., Louie L., et al. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrob Agents Chemother 2007, 51(11):3880-3886.
71. Simor A.E., Phillips E., McGeer A., et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007, 44(2):178-185.
72. Robicsek A., Beaumont J.L., Thomson R.B., et al. Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk. Infect Control Hosp Epidemiol 2009, 30(7):623-632.
73. Hitomi S., Kubota M., Mori N., et al. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment. J Hosp Infect 2000, 46(2):123-129.
74. Gregory M.L., Eichenwald E.C., Puopolo K.M. Seven-year experience with a surveillance program to reduce methicillin-resistant Staphylococcus aureus colonization in a neonatal intensive care unit. Pediatrics 2009, 123(5). 790-6.